JHHC is a strategic advisor to the life sciences industry drawing on more than 20 years of experience across sales, marketing, account management, operations, market access, state and federal policy functions. With commercial experience in 10 therapeutic areas (including orphan and ultra-orphan disease states), and 40 marketed products (oral solid and injectable/IV) JHHC provides insights to pharmaceutical & biotech startup C-suites, leading investment firms and consultancies. Recent project focus has included: decision support for generic, reformulations, and biosimilars; organizational design and operational effectiveness for startups; commercial due diligence and business development support; corporate, franchise, and brand strategy; as well as primary and secondary market research.